Allergic bronchopulmonary aspergillosis

Insights

Allergic bronchopulmonary aspergillosis (ABPA) is rare, but this study found the antibiotic Hamycin effective in treating 7 patients. Hamycin showed good initial results, alleviating symptoms and clearing Aspergillus fumigatus from sputum.

Area of Science:

  • Medical Mycology
  • Pulmonology
  • Infectious Diseases

Background:

  • Allergic bronchopulmonary aspergillosis (ABPA) is an uncommon condition.
  • Asthma sensitization to Aspergillus antigen is prevalent globally due to the fungus's widespread presence.
  • The Mycology Department diagnosed 46 ABPA cases over 14 years.

Purpose of the Study:

  • To understand the disease evolution of Allergic bronchopulmonary aspergillosis.
  • To evaluate the efficacy of Hamycin in treating ABPA patients.

Main Methods:

  • Follow-up study of 17 Allergic bronchopulmonary aspergillosis patients.
  • Diagnosis confirmed by Aspergillus fumigatus in sputum and positive skin reactions.
  • Treatment group of 7 patients received oral Hamycin for 10 days.

Main Results:

  • Immediate positive outcomes observed in treated patients.
  • Marked alleviation of subjective symptoms reported.
  • Absence of Aspergillus fumigatus in sputum post-treatment.

Conclusions:

  • Hamycin demonstrates promising immediate results for Allergic bronchopulmonary aspergillosis treatment.
  • The antibiotic Hamycin warrants further clinical trials for ABPA management.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K